Neurology

What is Neurology?

Neurology is a branch of medical science that is concerned with disorders and diseases of the nervous system. The term neurology comes from a combination of two words - "neuron" meaning nerve and "logia" meaning "the study of".

What is the Difference Between Neurology and Neuroscience?

What is Neuroscience?

What is Neurosurgery?

What is Pediatric Neurology?

What is Neurotoxicity?

What is Neurooncology?

Neurological Infections

Neurogenetics: Genetics and Neurology

Signals from Gut Biome to Brain and Behavior

Neurogenesis

Lab-Grown Neurons

See more featured articles »

What are Mirror Neurons?

What is Neuronal Plasticity and Why Is It Important?

What are Neuroepithelial Cells?

What are Glutamate Receptors?

What are Neuronal Markers?

What are Neurotransmitters?

Using Antibodies for Parkinson's Disease Research

What are Glial Cells?

How are 'Strong' Memories Formed?

Latest Neurology News and Research

Researchers seek to revolutionize neurological disease treatment through intelligent biocomputing

With newly awarded funding from the National Science Foundation, researchers at the University of California, Irvine and the Keck School of Medicine of USC will seek to revolutionize the treatment of neurological diseases through intelligent biocomputing.

5 Sep 2024

New dye technique allows for transparent skin imaging in live mice

Seeing what's going on inside a body is never easy. While technologies like CT scans, X-rays, MRIs, and microscopy can provide insights, the images are rarely completely clear and can come with side effects like radiation exposure.

5 Sep 2024

Research uncovers unexpected origin of ataxia outside the cerebellum

A new study by the University of Turku and Turku University Hospital in Finland investigated the origin of ataxia in the brain of patients with stroke.

5 Sep 2024

New insights into stiff-person syndrome, advancing diagnosis and treatment

Research explores the complexities of diagnosing and treating stiff-person syndrome, emphasizing the uncertain role of GAD antibodies and the promise of novel therapies.

5 Sep 2024

Study links cadmium exposure to cognitive decline in white individuals

The heavy metal cadmium, which is found in the air, water, food and soil, is known to cause health problems.

4 Sep 2024

Novel intermediate form of serotonin receptor identified as therapeutic target for psychiatric disorders

Misha Kudryshev's lab at the Max Delbrück Center has identified a molecular intermediate of a serotonin receptor that is involved in diseases such as depression and schizophrenia.

4 Sep 2024

Sports concussions may not be related to long-term cognitive risks for non-professional athletes

Sports-related concussions (SRC) may not be associated with long-term cognitive risks for non-professional athletes, a study led by a UNSW medical researcher suggests.

4 Sep 2024

Avadel Pharmaceuticals announces publication of RESTORE data highlighting challenges with twice-nightly oxybates and strong patient preference for once-nightly LUMRYZ™ dosing (sodium oxybate) extended-release oral suspension (CIII)

Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, today announced the publication of final data from the RESTORE open-label/switch study, demonstrating that people with narcolepsy prefer once-at-bedtime LUMRYZ versus a twice-nightly immediate-release oxybate treatment option.

From Avadel Pharmaceuticals 4 Sep 2024

Major trial to test multiple drugs for progressive supranuclear palsy

A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative disorder that usually kills within seven years after symptoms start.

3 Sep 2024

New protocol explores the combination of aerobic exercise and cognitive rehabilitation for MS patients

Researchers at Kessler Foundation have published a new clinical protocol examining the combination of aerobic exercise and cognitive rehabilitation to improve learning and memory in individuals with multiple sclerosis (MS) who have mobility disability.

3 Sep 2024

Acute kidney injury doubles dementia risk, study finds

Study reveals a significant association between acute kidney injury (AKI) and an increased risk of dementia, particularly in cases of severe or recurrent AKI.

29 Aug 2024

Study reveals a new target for universal treatment for autoimmune diseases

More than two decades ago, a research team in the lab of David Hafler, a Yale researcher who at the time was at Harvard, discovered a type of T cell in humans that suppresses the immune system; they later found that these so-called regulatory T cells, when defective, are an underlying cause of autoimmune disease, specifically multiple sclerosis (MS).

28 Aug 2024

Researchers identify key cellular interactions driving Alzheimer's and aging

An analysis of more than 1.6 million brain cells from older adults has captured the cellular changes that occur in the early stages of Alzheimer's disease, potentially revealing new routes for preventing the most common cause of dementia in older individuals.

28 Aug 2024

Acute kidney injury linked to increased risk of dementia

Acute kidney injury is associated with an increased risk of developing dementia, according to a new study published in the journal Neurology by researchers at Karolinska Institutet and others.

26 Aug 2024

Multiple sclerosis patients less likely to have molecular hallmarks of Alzheimer's disease

People with multiple sclerosis (MS) are far less likely than those without the condition to have the molecular hallmarks of Alzheimer's disease, according to new research from Washington University School of Medicine in St. Louis.

23 Aug 2024

Study reveals bidirectional relationship between diabetes complications and mental health disorders

Heart attack, stroke, nerve damage. These are just some of the complications for which millions of Americans with diabetes are at greater risk.

23 Aug 2024

Cancer drug holds promise as a new treatment for neurodegenerative diseases

A type of drug developed for treating cancer holds promise as a new treatment for neurodegenerative diseases such as Alzheimer's, according to a recent study by researchers at Penn State, Stanford University and an international team of collaborators.

22 Aug 2024

Study challenges migraine-Parkinson's connection

Contrary to previous research, a new study of female participants finds no link between migraine and the risk of developing Parkinson's disease. The study was published on August 21st, 2024, in the online issue of Neurology®, the medical journal of the American Academy of Neurology.

22 Aug 2024

Study reveals gaps in Alzheimer's knowledge

A new study examining older Black Americans' perceptions of Alzheimer's disease has found a lack of awareness of the devastating condition. The authors propose strategies for supporting brain health in this population.

21 Aug 2024

Aceneuramic acid drug receives approval for treatment of patients with GNE myopathy

In order to treat an underserved population of patients with a rare condition whose muscles gradually become weaker until they can no longer walk, a team of researchers across Japan have completed a clinical study to confirm the safety of long-term administration of a therapeutic drug.

20 Aug 2024